{"id":"https://openalex.org/W1990109497","doi":"https://doi.org/10.1179/joc.2008.20.3.368","title":"Oral Vinorelbine as First Line Chemotherapy in Unfit Elderly Patients with Hormone-Refractory Prostate Cancer","display_name":"Oral Vinorelbine as First Line Chemotherapy in Unfit Elderly Patients with Hormone-Refractory Prostate Cancer","publication_year":2008,"publication_date":"2008-06-01","ids":{"openalex":"https://openalex.org/W1990109497","doi":"https://doi.org/10.1179/joc.2008.20.3.368","mag":"1990109497","pmid":"https://pubmed.ncbi.nlm.nih.gov/18606594"},"language":"en","primary_location":{"id":"doi:10.1179/joc.2008.20.3.368","doi":"https://doi.org/10.1179/joc.2008.20.3.368","is_oa":false,"landing_page_url":"https://doi.org/10.1179/joc.2008.20.3.368","pdf_url":null,"source":{"id":"https://openalex.org/S127202688","display_name":"Journal of Chemotherapy","issn_l":"1120-009X","issn":["1120-009X","1973-9478"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055103616","display_name":"N. Caristi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139630","display_name":"Azienda Ospedaliera Universitaria Policlinico \"G. Martino\"","ror":"https://ror.org/03tf96d34","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210139630"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"N. Caristi","raw_affiliation_strings":["Unit\u00e0 Operativa di Oncologia Medica, Azienda Ospedaliera Universitaria, Policlinico G Martino Messina, Italy. nicolacaristi@libero.it","Unit\u00e0 Operativa di Oncologia Medica, Azienda Ospedaliera Universitaria, Policlinico G Martino Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e0 Operativa di Oncologia Medica, Azienda Ospedaliera Universitaria, Policlinico G Martino Messina, Italy. nicolacaristi@libero.it","institution_ids":["https://openalex.org/I4210139630"]},{"raw_affiliation_string":"Unit\u00e0 Operativa di Oncologia Medica, Azienda Ospedaliera Universitaria, Policlinico G Martino Messina, Italy","institution_ids":["https://openalex.org/I4210139630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021823365","display_name":"Roberto Maisano","orcid":"https://orcid.org/0000-0003-3051-1023","observed_orcids":["https://orcid.org/0000-0003-3051-1023"]},"institutions":[{"id":"https://openalex.org/I4210098397","display_name":"Azienda ospedaliera \"Bianchi-Melacrino-Morelli\"","ror":"https://ror.org/00z28d984","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210098397"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"R. Maisano","raw_affiliation_strings":["Azienda Ospedaliera Bianchi-Melacrino-Morelli"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Azienda Ospedaliera Bianchi-Melacrino-Morelli","institution_ids":["https://openalex.org/I4210098397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004014362","display_name":"Monica Iorfida","orcid":"https://orcid.org/0000-0001-9654-8385","observed_orcids":["https://orcid.org/0000-0001-9654-8385"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Iorfida","raw_affiliation_strings":["Istituto Europeo di Oncologia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Europeo di Oncologia","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049271920","display_name":"Antonino Scimone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Scimone","raw_affiliation_strings":["University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013635193","display_name":"Giuseppe Lupo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Lupo","raw_affiliation_strings":["University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109519952","display_name":"Carmelo Antonio Buda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C. Buda","raw_affiliation_strings":["University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088049125","display_name":"Claudio Scisca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C. Scisca","raw_affiliation_strings":["University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054443196","display_name":"Vincenzo Adamo","orcid":"https://orcid.org/0000-0003-2074-2418","observed_orcids":["https://orcid.org/0000-0003-2074-2418"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"V. Adamo","raw_affiliation_strings":["University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Messina","institution_ids":["https://openalex.org/I112862951"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2222,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.57580205,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"20","issue":"3","first_page":"368","last_page":"373"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.9610000252723694},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.8840000033378601},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.8560000061988831},{"id":"https://openalex.org/keywords/unfit-patients","display_name":"unfit patients","score":0.7850000262260437},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9259999990463257},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.8109999895095825},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.8650000095367432},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9629999995231628},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7329999804496765},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.3970000147819519}],"concepts":[{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.9451923370361328},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7571326494216919},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.6880130767822266},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6718176007270813},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6079820990562439},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5621544122695923},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5003132820129395},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4788665473461151},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4512372314929962},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.44794371724128723},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.4452456831932068},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.42764273285865784},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.42301106452941895},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3817603290081024},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37659764289855957},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077235","descriptor_name":"Vinorelbine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006410","descriptor_name":"Hematopoiesis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1179/joc.2008.20.3.368","doi":"https://doi.org/10.1179/joc.2008.20.3.368","is_oa":false,"landing_page_url":"https://doi.org/10.1179/joc.2008.20.3.368","pdf_url":null,"source":{"id":"https://openalex.org/S127202688","display_name":"Journal of Chemotherapy","issn_l":"1120-009X","issn":["1120-009X","1973-9478"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chemotherapy","raw_type":"journal-article"},{"id":"pmid:18606594","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18606594","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of chemotherapy (Florence, Italy)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W2084518320","https://openalex.org/W2157549109","https://openalex.org/W2159356788","https://openalex.org/W3041047318"],"related_works":["https://openalex.org/W2589729304","https://openalex.org/W2589536748","https://openalex.org/W4234222353","https://openalex.org/W2261499473","https://openalex.org/W107899007","https://openalex.org/W2088654336","https://openalex.org/W2410257389","https://openalex.org/W2257319321","https://openalex.org/W4234974619","https://openalex.org/W2092986324"],"abstract_inverted_index":{"Hormone-refractory":[0],"prostate":[1],"cancer":[2],"(HRPC)":[3],"is":[4,29,51,156],"a":[5,30,38],"rapidly":[6],"progressive":[7],"disease":[8],"which":[9],"produces":[10],"considerable":[11],"morbidity":[12],"and":[13,21,37,42,68,90,103,117,131,158,164,172],"involves":[14],"mostly":[15],"men":[16],"over":[17],"70,":[18],"often":[19],"comorbid":[20],"with":[22,83,162],"poor":[23],"tolerance":[24],"to":[25,59,96],"chemotherapy.":[26],"Low-toxicity":[27],"chemotherapy":[28],"reasonable":[31],"option":[32,176],"in":[33,46,71,137,167,177],"this":[34],"setting.":[35],"Vinorelbine":[36],"corticosteroid":[39],"show":[40],"activity":[41],"clinical":[43,66,134,165],"benefit":[44,67],"responses":[45,130,166],"HRPC.":[47],"An":[48],"oral":[49,84],"regimen":[50],"preferable":[52],"for":[53],"elderly":[54,73,179],"patients.":[55,75,181],"This":[56],"study":[57],"aimed":[58],"evaluate":[60],"safety,":[61],"prostate-specific":[62],"antigen":[63],"(PSA)":[64],"response,":[65],"progression-free":[69,142],"survival":[70,143,149],"chemonaive":[72],"HRPC":[74,180],"33":[76],"men,":[77],"median":[78,147],"age":[79],"78.2,":[80],"were":[81],"treated":[82],"vinorelbine":[85,153],"60":[86,115],"mg/m2":[87,98,116],"days":[88],"1":[89],"8":[91],"every":[92],"3":[93],"weeks,":[94,146],"escalable":[95],"80":[97,120],"after":[99],"the":[100],"first":[101],"cycle,":[102],"prednisone":[104,155],"5":[105,138],"mg":[106],"b.i.d.":[107],"The":[108],"main":[109],"toxicity":[110],"was":[111,144],"hematopoietic":[112],"(mild":[113],"at":[114,119],"moderate":[118,160],"mg/m2).":[121],"Of":[122],"27":[123],"evaluable":[124],"patients,":[125],"9":[126,132],"(33%)":[127],"had":[128,133],"PSA":[129],"benefit,":[135],"PSA-correlated":[136],"cases":[139],"(56%).":[140],"Median":[141],"13.4":[145],"overall":[148],"45":[150],"weeks.":[151],"Oral":[152],"plus":[154],"safe":[157],"has":[159],"activity,":[161],"biochemical":[163],"about":[168],"one-third":[169],"of":[170],"patients":[171],"could":[173],"be":[174],"an":[175],"unfit":[178]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}